Stage III Prostate Cancer (DBCOND0028656)

Identifiers

Synonyms
Prostate cancer stage III / Carcinoma of the prostate stage III / Prostatic cancer stage III

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03514927
High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate CancerNo drug interventionstreatmentNot Availablewithdrawn
NCT03432780
Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancerprevention2unknown_status
NCT03103321
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate CancerNo drug interventionshealth_services_research3completed
NCT01023061
Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancertreatment2completed
NCT02217709
Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancertreatment2completed
NCT02278185
Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancersupportive_care2active_not_recruiting
NCT01028885
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the ProstateNo drug interventionstreatment1completed
NCT01882985
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patientstreatment2completed
NCT00108732
A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancertreatment2completed
NCT01555632
Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation TherapytreatmentNot Availablewithdrawn
NCT02420652
Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapytreatment2terminated
NCT00466752
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancertreatment2completed
NCT01385059
Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancertreatment2completed
NCT02846870
Visually Enhanced Education About Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00450749
Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancertreatment2completed
NCT00996749
Omega-3 Fatty Acids in Treating Patients With Advanced Prostate CancerNo drug interventionstreatmentNot Availablewithdrawn
NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutationstreatment0completed
NCT00879619
Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patientstreatment1 / 2terminated
NCT00003517
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancertreatment2withdrawn
NCT01992016
A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor RanolazinediagnosticNot Availablecompleted
NCT01117935
Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT02023463
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancertreatment1active_not_recruiting
NCT00074022
GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumorstreatment1 / 2completed
NCT01664130
High-Dose Stereotactic Radiation for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00170157
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancertreatment2completed
NCT02605226
Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate CancertreatmentNot Availableunknown_status
NCT01703065
Cabozantinib in Men With Castration-Resistant Prostate Cancertreatment2terminated
NCT00103194
Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancertreatment2completed
NCT01823562
Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing SurgeryNo drug interventionstreatment1active_not_recruiting
NCT02296229
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01656304
Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapytreatment2completed
NCT00589472
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancertreatment2completed
NCT00937768
Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomytreatment2terminated
NCT01469338
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxelsupportive_care2terminated
NCT03477864
Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancertreatment1withdrawn
NCT02767921
sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancertreatment1terminated
NCT01126879
Genistein in Treating Patients With Prostate CancerNo drug interventionstreatment2terminated
NCT02346253
High-Dose Brachytherapy in Treating Patients With Prostate CancertreatmentNot Availableactive_not_recruiting
NCT04007770
Acupuncture Pilot Study for Cancer-related Cognitive FunctionNo drug interventionstreatment2active_not_recruiting
NCT01923506
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing SurgeryNo drug interventionstreatment1active_not_recruiting
NCT02144649
Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT01155258
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumorstreatment1completed
NCT00956163
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate CancerNo drug interventionsdiagnostic0completed
NCT03963739
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03880422
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availablerecruiting
NCT05025748
Ask Questions (ASQ):Implementation of a Communication InterventionNo drug interventionshealth_services_researchNot Availablecompleted
NCT02603965
Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing SurgeryNo drug interventionsdiagnostic1completed
NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neutreatment1completed
NCT01912820
Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgeryprevention1completed
NCT00536991
Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancertreatment1 / 2terminated
NCT03112668
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their PartnersNo drug interventionssupportive_careNot Availablecompleted
NCT04589468
Researching the Effect of Exercise on CancerNo drug interventionspreventionNot Availablerecruiting
NCT01731912
Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate CancertreatmentNot Availablecompleted
NCT00058214
Perifosine in Treating Patients With Recurrent Prostate Cancertreatment2terminated
NCT02048150
Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate CancerNo drug interventionsdiagnostic1completed
NCT00121238
Cilengitide in Treating Patients With Prostate Cancertreatment2completed